These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 7752176

  • 1. Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: a double-blind, cross-over study.
    Lind L, Berne C, Pollare T, Lithell H.
    J Hum Hypertens; 1995 Feb; 9(2):137-41. PubMed ID: 7752176
    [Abstract] [Full Text] [Related]

  • 2. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP, Joglekar SJ, Mukherjee S, Nanivadekar AS.
    J Assoc Physicians India; 1998 Feb; Suppl 1():30-40. PubMed ID: 11233385
    [Abstract] [Full Text] [Related]

  • 3. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 Feb; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of selective alfa 1 and beta 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity.
    Andersson PE, Johansson J, Berne C, Lithell H.
    J Hum Hypertens; 1994 Mar; 8(3):219-26. PubMed ID: 8006923
    [Abstract] [Full Text] [Related]

  • 6. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD, Garcia-Puig J, Charbonnel B, Angelkort B, Barnett AH.
    J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Does long-term blood pressure reduction in patients with essential hypertension improve concomitant metabolic disorders?].
    Hauner H, Meissner C.
    Med Klin (Munich); 1994 Aug 15; 89(8):403-9. PubMed ID: 7968872
    [Abstract] [Full Text] [Related]

  • 10. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.
    Am Heart J; 2003 Mar 15; 145(3):459-66. PubMed ID: 12660669
    [Abstract] [Full Text] [Related]

  • 11. Is insulin resistance a predictor of the blood pressure response to anti-hypertensive treatment?
    Lind L, Berne C, Andersson PE, Hänni A, Lithell H.
    J Hum Hypertens; 1995 Sep 15; 9(9):759-63. PubMed ID: 8551491
    [Abstract] [Full Text] [Related]

  • 12. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Nov 15; 16(11):1357-69. PubMed ID: 9856375
    [Abstract] [Full Text] [Related]

  • 13. Lipids and cardiovascular reactivity changes in hypertensive cigarette smokers: enalapril versus nifedipine treatment effects.
    Nazzaro P, Cicco G, Manzari M, Merlo M, Pirrelli A.
    Am J Med Sci; 1994 Feb 15; 307 Suppl 1():S150-3. PubMed ID: 8141156
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of insulin resistance in essential hypertension.
    Lind L, Berne C, Lithell H.
    J Hypertens; 1995 Dec 15; 13(12 Pt 1):1457-62. PubMed ID: 8866908
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, controlled, multicenter, randomized study comparing the antihypertensive effectiveness and tolerance of a daily dose of two nifedipine formulations: nifedipine microgranules versus nifedipine osmotic pump.
    de Roa ER, Botero R, Octavio JA, Berrizbeitia ML, Mayorca E, Castro P, Miranda R, Valecillo E, Aroca G, Aza G, González M.
    Am J Ther; 2007 Dec 15; 14(2):140-6. PubMed ID: 17414581
    [Abstract] [Full Text] [Related]

  • 16. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G, Italian Study Group on Nilvadipine in Mild to Moderate Hypertension.
    Curr Med Res Opin; 2005 Jun 15; 21(6):951-8. PubMed ID: 15969895
    [Abstract] [Full Text] [Related]

  • 17. Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.
    Ohnishi K, Kohno M, Yukiiri K, Masugata H, Wada Y, Takagi Y, Ohmori K.
    Int J Clin Pharmacol Ther; 2001 Oct 15; 39(10):417-22. PubMed ID: 11680666
    [Abstract] [Full Text] [Related]

  • 18. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 15; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 19. Nifedipine vs. enalapril in treatment of hypertensive patients with glucose intolerance.
    Andronico G, Piazza G, Mangano MT, Mule G, Carone MB, Cerasola G.
    J Cardiovasc Pharmacol; 1991 Mar 15; 18 Suppl 10():S52-4. PubMed ID: 1725004
    [Abstract] [Full Text] [Related]

  • 20. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G, Cicero AF, Murdolo G, Ciccarelli L, Fogari R.
    Diabetes Nutr Metab; 2004 Aug 15; 17(4):222-9. PubMed ID: 15575343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.